| Sarah Kennelly, NP | |
|
1220 Sheyenne St, West Fargo, ND 58078-2637 | |
| (701) 367-9379 | |
| Not Available |
| Full Name | Sarah Kennelly |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1220 Sheyenne St, West Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962981845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | F08180406 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry.
Patients with Crohn's disease who have failed to respond adequately to anti–tumor necrosis factor treatment may benefit from the monoclonal antibody ustekinumab, results of a double-blind, placebo-controlled trial suggest.
Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.
Researchers in the United States have demonstrated a potential new approach to treating infection with the new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry.
Patients with Crohn's disease who have failed to respond adequately to anti–tumor necrosis factor treatment may benefit from the monoclonal antibody ustekinumab, results of a double-blind, placebo-controlled trial suggest.
Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.
Researchers in the United States have demonstrated a potential new approach to treating infection with the new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry.
Patients with Crohn's disease who have failed to respond adequately to anti–tumor necrosis factor treatment may benefit from the monoclonal antibody ustekinumab, results of a double-blind, placebo-controlled trial suggest.
Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.
Researchers in the United States have demonstrated a potential new approach to treating infection with the new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Kennelly, NP Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Sarah Kennelly, NP 1220 Sheyenne St, West Fargo, ND 58078-2637 Ph: (701) 367-9379 |
News Archive
BioMedGPS, the leader in healthcare business intelligence and competitive metrics, announces the launch of FastTRAK B.I., a new business intelligence service designed specifically for the life science industry.
Patients with Crohn's disease who have failed to respond adequately to anti–tumor necrosis factor treatment may benefit from the monoclonal antibody ustekinumab, results of a double-blind, placebo-controlled trial suggest.
Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.
Researchers in the United States have demonstrated a potential new approach to treating infection with the new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 1 days ago
James Troy Upton, APRN, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3306 Sheyenne St Ste 216, West Fargo, ND 58078 Phone: 701-532-1731 Fax: 701-532-1940 | |
Cynthia Nicole Vingelen, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1220 Sheyenne St, West Fargo, ND 58078 Phone: 701-234-4445 | |
Patricia K Slyter, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1401 13th Ave E, West Fargo, ND 58078 Phone: 701-364-0060 Fax: 701-364-0065 | |
Dr. Jenna Rose Wallace, DNP, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1220 Sheyenne St, West Fargo, ND 58078 Phone: 701-234-4445 Fax: 701-234-4456 | |
Cassie Marie Moores Kristensen, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1417 12th Street Ct, West Fargo, ND 58078 Phone: 415-278-1574 | |
Molly Christine Mcmanus, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1401 13th Avenue East, West Fargo, ND 58078 Phone: 701-364-5722 | |
Marjorie Masten, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1401 13th Ave E, West Fargo, ND 58078 Phone: 701-364-5751 |